Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q3 2024 Earnings

6AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-4

-2.42

-0.83

0.75

Details

Expected EPS

-4

Actual EPS

0.75

Surprise EPS

4.75

Surprise Percent

+118.75%

Description

Aligos Therapeutics (ALGS) has reported earnings of 0.75 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.